We are live on ! Find out more
PAVMZ

PAVmed Inc. Series Z Warrant
PAVMZ

Delisted

PAVMZ was delisted on the 30th of April, 2025.

Back to rankings

7 hedge funds and large institutions have $906K invested in PAVmed Inc. Series Z Warrant in 2021 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% less funds holding

Funds holding: 8 → 7 (-1)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

82% less capital invested

Capital invested by funds: $5.07M → $906K (-$4.17M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$2.8K

Top Sellers

Rank Fund Capital Flow
1
WAM
Warberg Asset Management
Illinois
-$372K
2
VF
Virtu Financial
New York
-$151K
3
WAM
Wolverine Asset Management
Illinois
-$128K
4
UBS Group
UBS Group
Switzerland
-$6.79K

PAVMZ Hedge Fund Activity: Q4 2021 in Review

7 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q4 2021, worth a combined $906K — down 82% from $5.07M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of PAVMZ and 0 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.

The largest buyer was Morgan Stanley, adding an estimated $2.8K. The largest seller was Warberg Asset Management, cutting an estimated $372K.

  • 7 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q4 2021, down from 8 in Q3 2021.
  • Funds reported $906K of PAVmed Inc. Series Z Warrant stock for Q4 2021, down 82% quarter-over-quarter.
  • 0 funds opened new PAVmed Inc. Series Z Warrant positions in Q4 2021 and 1 closed out, a net change of -1 holder.
  • The largest PAVmed Inc. Series Z Warrant buyer in Q4 2021 was Morgan Stanley, an estimated $2.8K added.
  • The largest PAVmed Inc. Series Z Warrant seller in Q4 2021 was Warberg Asset Management, an estimated $372K sold.

Based on aggregated 13F filings for Q4 2021.